Research programme: anticancer antibiotics - Astellas Pharma
Alternative Names: ThioviridamideLatest Information Update: 05 Feb 2008
At a glance
- Originator Astellas Pharma; University of Tokyo
- Class Cyclic peptides
- Mechanism of Action Apoptosis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 30 Jun 2006 A clinical study has been added to the Cancer pharmacodynamics section